临床荟萃

• 专题 • 上一篇    下一篇

慢性肾脏病合并糖尿病的治疗

  

  1. 河北医科大学第二医院 内分泌科,河北 石家庄 050000
  • 收稿日期:2016-04-15 出版日期:2016-06-05 发布日期:2016-06-06
  • 通讯作者: 通信作者:张松筠,Email:2574459696@qq.com
  • 作者简介:张松筠,女,医学博士,河北医科大学 第二医院内分泌科主任医师、教授、硕士 研究生导师。河北省医学会内分泌代谢 分会青年委员,河北省医学会行为学分会 常务委员。发表论著70余篇(SCI论文2 篇)。曾获河北省科技厅科技进步三等 奖、河北省卫生厅科技进步一、二等奖。 目前承担河北省自然科学基金1项、卫生 厅课题1项。

Treatment of chronic kidney disease with diabetes mellitus

  1. Department of Endocrinology, the Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
  • Received:2016-04-15 Online:2016-06-05 Published:2016-06-06
  • Contact: Corresponding author:Zhang Songyun,Email:2574459696@qq.com

摘要: 慢性肾脏病(CKD)合并糖尿病的治疗措施包括生活方式干预、降糖、降压、降脂、抗血小板及肾脏替代治
疗。所有治疗遵循安全、有效、个体化原则。生活方式干预强调低盐低蛋白饮食。治疗药物的选择及剂量的调整应基
于药物的药代动力学特征及肾功能水平。降糖药利格列汀、格列吡嗪、吡格列酮可全程应用于CKD无需调整剂量。
降压治疗首选肾素血管紧张素醛固酮系统阻滞剂。对于CKDG1~4期患者,推荐启用他汀类药物。抗血小板治
疗首选阿司匹林,不能耐受或有禁忌证者以氯吡格雷替代。透析启动时机与非糖尿病CKD患者相同。

关键词: 肾疾病, 糖尿病, 治疗

Abstract:

Treatment strategy in diabetic patients with chronic kidney disease(CKD) includes lifestyle  intervention, glycemic control, blood pressurelowering therapy, lipidlowering therapy, antiplatelet therapy and renal replacement therapy. All treatments follow the principle of safety, effectiveness and individualization. Lifestyle intervention focuses at the restriction of salt and protein intake. Drug selection and dose adaptation should be based on the pharmacokinetic characteristics and the renal function.  Linagliptin, glipizide and pioglitazone can be used through the CKD process without dose adjustment.  RAAS inhibitors should be considered as an initial therapy for hypertension. Statin is recommended in diabetic patients with CKD of stage 1 to  4. Aspirin is recommended as the first choice for antiplatelet therapy and clopidogrel is an alternative for aspirin in patients with clear intolerance or contraindications for aspirin. Dialysis is initiated in patients with diabetes on the same criteria as in those without diabetes.

Key words: kidney disease, diabetes mellitus, treatments